Pneumocystis jirovecii following rituximab

Rheumatology key messagesPneumocystis jirovecii pneumonia is an important differential in the immunosuppressed patient with new onset breathlessness.The onset ofPneumocystis jirovecii pneumonia may rapidly follow commencement of immunosuppression.With increasing use of prophylaxis againstPneumocystis jirovecii pneumonia, clinicians should be aware of potential drug toxicities.
Source: Rheumatology - Category: Rheumatology Source Type: research